Skip to main content
Clinical Trials/NCT04987359
NCT04987359
Active, not recruiting
Not Applicable

A Randomized Trial of a Multimodal Lifestyle Intervention to Optimize Survivorship After Cancer

Pennington Biomedical Research Center1 site in 1 country54 target enrollmentAugust 19, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Neoplasm Malignant
Sponsor
Pennington Biomedical Research Center
Enrollment
54
Locations
1
Primary Endpoint
Change in cardiorespiratory fitness capacity (co-primary)
Status
Active, not recruiting
Last Updated
10 months ago

Overview

Brief Summary

To examine the efficacy of a 10-week multimodal lifestyle program, versus waitlist control, on cardiorespiratory fitness capacity and body weight in survivors of cancer.

Registry
clinicaltrials.gov
Start Date
August 19, 2021
End Date
December 31, 2025
Last Updated
10 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Justin Brown

Assistant Professor

Pennington Biomedical Research Center

Eligibility Criteria

Inclusion Criteria

  • Ability to provide informed consent before any trial-related activities
  • History of any malignancy
  • Completion of cancer-directed therapy (e.g., surgery, chemotherapy, and radiotherapy) prior to enrollment (patients receiving ongoing endocrine or targeted therapy are eligible to participate)
  • No evidence of residual or recurrent cancer under active treatment
  • Age ≥18 years
  • Body mass index (BMI) ≥30 kg/m2 or BMI ≥27 kg/m2 with one or more treated or untreated weight-related coexisting conditions
  • Willing to be randomized
  • Allow the collection and storage of biospecimens and data for future use

Exclusion Criteria

  • Engaging in ≥3 purposeful exercise sessions per week, on average, over the past 12 weeks
  • Significant purposeful weight loss (\>11 kg) within the past 12 weeks
  • Current use of medications or devices for the purpose of weight loss
  • Metabolic or bariatric surgery within the last year
  • Cardiovascular, respiratory, or musculoskeletal disease that would prohibit participation in an exercise and weight loss program
  • Currently pregnant, breastfeeding, or planning to become pregnant with the next 12 weeks
  • Psychiatric disorders or conditions that would preclude participation in the study intervention
  • Any other condition which, in the opinion of the investigator, may impede testing of the study hypothesis or make it unsafe to engage in the study

Outcomes

Primary Outcomes

Change in cardiorespiratory fitness capacity (co-primary)

Time Frame: Baseline, Week 10

Cardiorespiratory fitness (VO2peak) assessed by a symptom-limited cardiopulmonary exercise test.

Change in body weight (co-primary)

Time Frame: Baseline, Week 10

Bodyweight assessed using a digital scale in a fasting state with an empty bladder, without shoes, and only wearing light clothing.

Secondary Outcomes

  • Change in systolic blood pressure(Baseline, Week 10)
  • Change in fat Mass(Baseline, Week 10)
  • Change in waist Circumference(Baseline, Week 10)
  • Change in diastolic blood pressure(Baseline, Week 10)
  • Change in physical and mental quality-of-life(Baseline, Week 10)
  • Change in medication use(Baseline, Week 10)

Study Sites (1)

Loading locations...

Similar Trials